Difference between revisions of "Loyola University Medical Center"
(→2006 Policy) |
(→Relevant Links) |
||
| (One intermediate revision by the same user not shown) | |||
| Line 29: | Line 29: | ||
[https://web.archive.org/web/20190828183118/https://hsd.luc.edu/media/healthsciencesdivision/researchservices/documents/intellectual-property.pdf 2010 Policy] | [https://web.archive.org/web/20190828183118/https://hsd.luc.edu/media/healthsciencesdivision/researchservices/documents/intellectual-property.pdf 2010 Policy] | ||
| + | |||
| + | ''"Net Revenue" represents Gross Revenue minus all expenses directly related to the prosecution and maintenance of any patents, licensing agreement(s), or other commercial arrangements. Fifteen percent (15%) of Gross Revenue is allocated to the respective Office of Research Services responsible for technology transfer administration expenses prior to the subtraction of any other expenses, including but not limited to the cost of litigation. Payments made under an externally-funded grant or contract are specifically excluded as revenue for the purpose of determining Net Revenue.'' | ||
Income Distribution | Income Distribution | ||
| Line 56: | Line 58: | ||
== Relevant Links == | == Relevant Links == | ||
| − | *https://web.archive.org/web/20190214211304/https://hsd.luc.edu/research_services/committees/technologytransfercommittee/ Loyola University Medical Center Tech Transfer Office] | + | *[https://web.archive.org/web/20190214211304/https://hsd.luc.edu/research_services/committees/technologytransfercommittee/ Loyola University Medical Center Tech Transfer Office] |
*[https://web.archive.org/web/20190828183118/https://hsd.luc.edu/media/healthsciencesdivision/researchservices/documents/intellectual-property.pdf Loyola IP & Technology Transfer Policy (2009)] | *[https://web.archive.org/web/20190828183118/https://hsd.luc.edu/media/healthsciencesdivision/researchservices/documents/intellectual-property.pdf Loyola IP & Technology Transfer Policy (2009)] | ||
*[http://universitypatentdata.com/images/9/9e/2006_LoyolaMed.pdf Loyola IP & Technology Transfer Policy (2006)] | *[http://universitypatentdata.com/images/9/9e/2006_LoyolaMed.pdf Loyola IP & Technology Transfer Policy (2006)] | ||
Latest revision as of 11:36, 28 August 2019
We were able to locate detailed patent royalty sharing information for the Loyola University Medical Center dating back to 2006.
Summary
| Institution | Start | End | Flat | $0-10k | $10-50k | $50-100k | $100-300k | $300-500k | $0.5-1M | >$1M | Fee | Lab | More |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Loyola University Medical Center | 2006 | 2009 | Yes | 0.50 | 0.50 | 0.50 | 0.50 | 0.50 | 0.50 | 0.50 | 0.125 | No | No |
| Loyola University Medical Center | 2010 | 2017 | No | 0.50 | 0.50 | 0.50 | 0.40 | 0.40 | 0.30 | 0.30 | 0.15 | No | No |
Policy Excerpts
Current Policy
"Net Revenue" represents Gross Revenue minus all expenses directly related to the prosecution and maintenance of any patents, licensing agreement(s), or other commercial arrangements. Fifteen percent (15%) of Gross Revenue is allocated to the respective Office of Research Services responsible for technology transfer administration expenses prior to the subtraction of any other expenses, including but not limited to the cost of litigation. Payments made under an externally-funded grant or contract are specifically excluded as revenue for the purpose of determining Net Revenue.
Income Distribution
| LUC Cumulative Net Revenue | Inventors | Office of Research Services | Inventor's School | University |
|---|---|---|---|---|
| $0-$100,000 | 50% | 25% | 25% | - |
| $100,001-$500K | 40% | 25% | 20% | 15% |
| $500,001+ | 30% | 20% | 20% | 30% |
2006 Policy
Net revenue represents gross revenue minus all expenses directly related to the prosecution of the patent and licensing agreement(s), and 12.5% of gross revenue, which is allocated to the Office of Research Services.
Distribution of net revenue:
- a. 50% to the inventor. If there are multiple inventors, the 50% allocation will be subdivided according to the apportionment agreed to at the time of invention disclosure.
- b. 15% to the Department in which the inventor has a primary academic appointment. Subdivision of this allocation to Institutes and Centers is determined by agreements between organizational heads of the entities involved.
- c. 25% to a General Technology Transfer Fund, which will be used to support technology transfer activities.
- d. 5% to the Dean-SSOM
- e. 5% to the President and Chief Executive Officer-LUHS
